Clinical Research Facility

Camden, New Jersey 08103

We've found

5 trials

at this facility

Mucopolysaccharidosis I (MPS I) Registry

Status: Enrolling, Phase
Updated: 12/31/1969

from

Camden, NJ

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

Status: Enrolling, Phase
Updated: 12/31/1969

from

Camden, NJ

Fabry Disease Registry

Status: Enrolling, Phase
Updated: 12/31/1969

from

Camden, NJ

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Camden, NJ

Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Camden, NJ

Use our guide to learn which trials are right for you!